ADORA3 and cancer: Recently, in a model of cancer chemotherapy-induced neuropathic pain, the A3AR agonist MRS5698 attenuated pro-inflammatory IL-1β production and promoted anti-inflammatory and neuroprotective IL-10 expression by regulating the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome [124].